Corneal collagen crosslinking (CXL) is a relatively new technique to reduce the progression of keratoconus. The technique can be performed with or without complete debridement of the corneal ...

An advisory panel of the US Food and Drug Administration (FDA) on February 24 recommended approval of a new drug that treats two eye disorders with corneal collagen crosslinking, but waved some yellow ...

Corneal collagen crosslinking (CXL), a procedure to strengthen the cornea originally devised to treat patients with keratoconus, is now also used to treat post-refractive surgery ectasia. It was ...

According to Cleveland Clinic ophthalmologist, Dr. William Dupps of the Cole Eye Institute, Keratoconus is a progressive disease usually diagnosed in the teens, but causes vision to worsen by the 20s ...

Corneal cross-linking is an in-office procedure that works to strengthen and stabilize the cornea in eyes that have weakness from keratoconus or ectasia. At Baylor Medicine, our cornea specialists are ...

To assess the effects of preoperative patient characteristics on clinical outcomes of corneal crosslinking (CXL) treatment in patients with progressive keratoconus. This retrospective study comprised ...

Corneal haze caused by collagen cross-linking in patients with keratoconus or ectasia after LASIK takes at least 1 year to resolve but does not affect clinical outcomes, a study found. According to ...

Please provide your email address to receive an email when new articles are posted on . In the world of technology, disruptors are sought-after and celebrated. When Roy S. Rubinfeld, MD, MA, led the ...

Keratoconus, a condition where the cornea grows thin and changes shape, can be treated through crosslinking. (Rawpixel pic) In 2018, Chantique (not her real name) checked in at an eye clinic and ...

Hyderabad: Collagen crosslinking (CXL) — a treatment that strengthens the cornea — is safe and useful for people with keratoconus, a condition where the cornea becomes thin and cone-shaped, says a new ...